Month: ខែមករា 2026
សហរដ្ឋអាមេរិក ធ្វើការវាយប្រហារ ‘ដ៏ធំធេង’ នៅក្នុងប្រទេសស៊ីរី
Trump កំពុងពិចារណាបើកការវាយប្រហារថ្មីៗនៅអ៊ីរ៉ង់ – NYT
ទ្រាំបប្រកាស “ស្ថានភាពបន្ទាន់” ដើម្បីការពារមូលនិធិប្រេងរបស់វេណេស៊ុយអេឡា ដែលត្រូវបានកាន់កាប់ដោយសហរដ្ឋអាមេរិក
Eurostat បង្ហាញពីការចំណាយដ៏ច្រើននៃទណ្ឌកម្មប្រឆាំងរុស្ស៊ីរបស់សហភាពអឺរ៉ុប
នាយករដ្ឋមន្ត្រីការពារជាតិអង់គ្លេសបញ្ជាក់អ្នកមេជាតិពិភពលោកដែលគាត់ចង់គ្រប់គ្រង
Excent Capital Launches World Cup 2026 Incentive Program for Global Partners
Mexico City, Mexico – January 10, 2026 – (SeaPRwire) – Excent Capital has announced the launch of a new incentive program for its global partner network, offering exclusive experiences connected to the 2026 World Cu as part of its ongoing commitment to long-term collaboration and partner engagement.
The initiative is designed to recognise partner performance and strengthen relationships through experiences that go beyond traditional rewards. Depending on performance tiers, partners may qualify for packages that include match tickets, travel arrangements, accommodation, and curated experiences in the United States during the tournament.
Rather than focusing solely on volume, the program is structured to encourage sustainable growth, strategic alignment, and continued collaboration between Excent Capital and its partners. The incentive tiers are linked to clearly defined performance benchmarks, ensuring transparency and consistency across regions.
“We work…
ប្រធានាធិបតីបារាំងចោទប្រកាន់សហរដ្ឋអាមេរិកថាវាបែកខ្នងសម្ព័ន្ធមិត្ត
ទ្រាំព្រមគាត់អាចធ្វើតាមវិធីវិច្ឆិកាលើក្រុង Greenland
ត្រាំព្រ។ គំរាមកំហែងនឹងធ្វើការវាយប្រហារនៅម៉ិកស៊ិក
ចក្រភពអង់គ្លេសនឹងចំណាយថវិកា ២៧០ លានដុល្លារលើកងទ័ពសម្រាប់ ‘កងកម្លាំងចម្រុះជាតិ’ នៅអ៊ុយក្រែន
Cathie Wood របស់ ARK Invest: សហរដ្ឋអាមេរិក ប្រហែលជាឆាប់ៗនេះ នឹងទិញ Bitcoin សម្រាប់ស្តុកបម្រុង
PromiCell, Inc. presents during JP Morgan’s 2026 Healthcare Conference
MIAMI, FL, Jan 10, 2026 – (ACN Newswire via SeaPRwire.com) – PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s lead asset PRO CAR – 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level).About PromiCell, Inc.PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 TCR T cel…















